The DOI matches its Crossref record; 58 of the 60 references it cites were found in a registry or an index.
Senolytic CAR T cells reverse senescence-associated pathologies
Open accessAbstract
Cellular senescence is characterized by stable cell-cycle arrest and a secretory program that modulates the tissue microenvironment1,2. Physiologically, senescence serves as a tumour-suppressive mechanism that prevents the expansion of premalignant cells3,4 and has a beneficial role in wound-healing responses5,6. Pathologically, the aberrant accumulation of senescent cells generates an inflammatory milieu that leads to chronic tissue damage and contributes to diseases such as liver and lung fibrosis, atherosclerosis, diabetes and osteoarthritis1,7. Accordingly, eliminating senescent cells from damaged tissues in mice ameliorates the symptoms of these pathologies and even promotes longevity1,2,8–10. Here we test the therapeutic concept that chimeric antigen receptor (CAR) T cells that target senescent cells can be effective senolytic agents. We identify the urokinase-type plasminogen activator receptor (uPAR)11 as a cell-surface protein that is broadly induced during senescence and show that uPAR-specific CAR T cells efficiently ablate senescent cells in vitro and in vivo. CAR T cells that target uPAR extend the survival of mice with lung adenocarcinoma that are treated with a senescence-inducing combination of drugs, and restore tissue homeostasis in mice in which liver fibrosis is induced chemically or by diet. These results establish the therapeutic potential of senolytic CAR T cells for senescence-associated diseases. Chimeric antigen receptor (CAR) T cells targeting uPAR, a cell-surface protein that is upregulated on senescent cells, eliminate senescent cells in vitro and in vivo and reduce liver fibrosis in mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Certain cell surface proteins tend to be more highly expressed by senescent cells than most other cell types, which prompted development of engineered chimeric antigen receptor (CAR) T cells, vaccines and antibody–drug conjugates targeting these cell surface markers.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [96]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Each of these approaches eliminates senescent cells, although in some cases, activated macrophages and other non-senescent cell types are also affected96–99.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [96]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It was found that anti-uPAR-CAR-T cells were effective in removing senescent cells in vitro and pre-cancerous and malignant cells in mouse models of liver and lung in the presence of potentially toxic.350”
From Inflammation and aging: signaling pathways and intervention therapies (2023) · cites this paper as [350]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mice with lung adenocarcinomas were first exposed to a combination of MEK and CDK4/6 inhibitors to induce senescence, and then received uPAR- targeting CAR Tcells to selectively kill those senescent cells, leading to a marked delay in tumour growth 22 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [22]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Genome-wide CRISPR screens and transcriptomic profiling have identified several promising SnC-specific targets, with urokinase-type plasminogen activator receptor (uPAR) emerging as a leading candidate63,64”
From Emerging strategies in senotherapeutics: from broad-spectrum senolysis to precision reprogramming (2026) · cites this paper as [63]
Experimental — accuracy not yet measured
The cited source says what the claim attributes to it.
In the citing paper
“Exciting recent work has demonstrated that senolytic CAR T cell therapy can attenuate senescence-associated diseases226.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [226]
The cited source says what the claim attributes to it.
In the citing paper
“and PLAUR (uPAR) is associated with extracellular remodeling and increased secretion by senescent cells (Amor et al, 2020).”
From Distinct senotypes in p16- and p21-positive cells across human and mouse aging tissues (2025) · cites this paper as Amor et al, 2020
The cited source says what the claim attributes to it.
In the citing paper
“Amor et al. (2020) engineered chimeric antigen receptor (CAR) T cells recognizing uPAR, a protein expressed by senescent cells, a strategy that mirrors normal senescence immunosurveillance.”
From Senescence and the SASP: many therapeutic avenues (2020) · cites this paper as Amor et al. 2020
The cited source says what the claim attributes to it.
In the citing paper
“these “senolytic CAR T cells” can be used not just as an anticancer therapy, but to treat other senescence-associated disorders, such as nonalcoholic steatohepatitis (NASH) (Amor et al. 2020).”
From Senescence and the SASP: many therapeutic avenues (2020) · cites this paper as Amor et al. 2020
The cited source says what the claim attributes to it.
In the citing paper
“Other plasma membrane proteins whose expression has also been reported to change during senescence are receptor- type tyrosine protein phosphatase DEP-1, β 2 -microglobulin, membrane- bound oxidized vimentin, dipeptidyl peptidase 4 and urokinase- type plasminogen activator receptor (uPAR) 22,61,62 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, CAR Tcells targeting uPAR on the surface of senescent cells have been developed as promising cell- based senolytics 22 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“chimeric antigen receptor redirected T (CAR-T) cells that target the senescent cell-specific surface molecule uPA receptor [116]”
From The role of cellular senescence and SASP in tumour microenvironment (2023) · cites this paper as [116]
The cited source says what the claim attributes to it.
In the citing paper
“In particular, antibodies directed against the glycoprotein NMB (GPNMB) 202 and CAR T cells directed against the receptor uPAR 203 attenuate senescence-associated disease models in mice.”
From Hallmarks of aging: An expanding universe (2023) · cites this paper as [203]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Additionally, CXCL16 is upregulated in aging and inflammatory conditions linked to senescence”
From Distinct senotypes in p16- and p21-positive cells across human and mouse aging tissues (2025) · cites this paper as Amor et al, 2020
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“transplantation of a small proportion of senescent cells or injection of chimeric antigen receptor (CAR) Tcells with a senescent phenotype accelerated physical dysfunction and reduced lifespan 21,22”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [22]
Experimental — accuracy not yet measuredIn the citing paper
“This approach was successfully validated by a study that used CAR-T to deplete only HSCs that expressed the senescence marker urokinase plasminogen activator receptor (uPAR), thereby improving inflammation and fibrosis (128).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [128]
In the citing paper
“In mouse models, CAR T cells directed against uPAR (urokinase-type plasminogen activator receptor), which is abundantly present on senescent cells, ameliorates experimental liver fibrosis.146”
From An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH (2023) · cites this paper as [146]
In the citing paper
“Moreover, recent studies have shown that uPAR-specific CAR-T cells can effectively eliminate senescent cells in vitro and in vivo and prolong the survival of lung adenocarcinoma mice [127].”
From Immunosenescence: a key player in cancer development (2020) · cites this paper as [127]
In the citing paper
“Studies have begun to reveal the remarkable heterogeneity of cellular senescence in different tissues, highlighting the importance of cellular senescence markers beyond p16 – including Cdkn1a (p21) [7–10], Cdkn2d (p19) [11], uPAR [12], and glycoprotein non-metastatic melanoma protein B (GPNMB) [13] – and emphasizing the urgent need for a better understanding of senescent cell heterogeneity.”
From The heterogeneity of cellular senescence: insights at the single-cell level (2023) · cites this paper as [12]
In the citing paper
“In another study, urokinase plasminogen activator receptor (uPAR), was identified as a unique senescence marker by comparing differentially expressed genes in bulk RNA-seq datasets of three known mouse models of senescence, and was validated by flow cytometry [12].”
From The heterogeneity of cellular senescence: insights at the single-cell level (2023) · cites this paper as [12]
In the citing paper
“Elimination of uPAR-expressing cells with chimeric antigen receptor (CAR) T cells specifically kills senescent cells both in vivo and in vitro, and extends the lifespan of mice with lung adenocarcinoma [12].”
From The heterogeneity of cellular senescence: insights at the single-cell level (2023) · cites this paper as [12]
In the citing paper
“Similarly, chimeric antigen receptor (CAR) T cells targeting the urokinase-type plasminogen activator receptor (uPAR), reported to be a specific cell surface marker in certain senescent cell populations, effectively ablated senescent cells in vitro and in murine models of lung adenocarcinomas and liver fibrosis (49).”
From Exercise Counters the Age-Related Accumulation of Senescent Cells (2022) · cites this paper as [49]
In the citing paper
“The success of immunotherapies in different forms of cancer have also led to proof-of-concept studies for targeting senescent cells (Amor et al., 2020; Kim et al., 2017).”
From Skeletal muscle aging, cellular senescence, and senotherapeutics: current knowledge and future directions (2021) · cites this paper as Amor et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Trimmomatic: a flexible trimmer for Illumina sequence data
Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219
Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool
Chen, E. Y., Tan, C. M., Kou, Y., Duan, Q., Wang, Z., Meirelles, G. V., Clark, N. R., & Ma’ayan, A. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-128 · Cited by 7,814
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Self-citationClearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
Park, J. H., Rivière, I., Gonen, M., Wang, X., Sénéchal, B., Curran, K. J., Sauter, C., Wang, Y., Santomasso, B., Mead, E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1709919 · Cited by 2,688
Self-citationSenolytics improve physical function and increase lifespan in old age
Xu, M., Pirtskhalava, T., Farr, J. N., Weigand, B. M., Palmer, A. K., Weivoda, M. M., Inman, C. L., Ogrodnik, M. B., Hachfeld, C. M., Fraser, D. G., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0092-9 · Cited by 2,287
An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Cited by
Sorted by citations
Items 701–800 of 1,003
Establishing evidence for immune surveillance of β-cell senescence
Morelli, N. R., Pipella, J., & Thompson, P. J. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.01.003 · Cited by 7
Targeting Senescence for Next-Generation Cancer Treatments
Gilson, É., Soubeyran, P., & Solary, É. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0089 · Cited by 7
Chen, W., Guo, L., Xu, H., Dai, Y., Yao, J., & Wang, L. (2024) · Oncogenesis · doi:10.1038/s41389-024-00515-4 · Cited by 7
Innovative cell therapies for systemic sclerosis: available evidence and new perspectives
Lescoat, A., Ghosh, M., Kadauke, S., & Khanna, D. (2024) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2024.2402494 · Cited by 7
Liddiard, K., Grimstead, J. W., Cleal, K., Evans, A., & Baird, D. M. (2021) · NAR Cancer · doi:10.1093/narcan/zcaa044 · Cited by 7
Mechanism of andrographis paniculata on lung cancer by network pharmacology and molecular docking
Li, J., Liu, X., Li, J., Han, D., Li, Y., & Ge, P. (2023) · Technology and Health Care · doi:10.3233/thc-220698 · Cited by 7
D ipeptidylpeptidase‐4‐targeted activatable fluorescent probes visualize senescent cells
Tanaka, H., Sugawara, S., Tanaka, Y., Loo, T. M., Tachibana, R., Abe, A., Kamiya, M., Urano, Y., & Takahashi, A. (2024) · Cancer Science · doi:10.1111/cas.16229 · Cited by 7
Targeting senescent cells and tumor therapy (Review)
Wang, Z., Gao, J., Liu, H., Ohno, Y., & Xu, C. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4705 · Cited by 8
Epperly, M. W., Shields, D. S., Fisher, R., Hou, W., Wang, H., Hamade, D. F., Mukherjee, A., & Greenberger, J. S. (2021) · Radiation Research · doi:10.1667/rade-20-00286.1 · Cited by 8
The interplay between senescence, inflammation, and the immune systemPreprint
Gil, J. (2025) · Genes & Development · doi:10.1101/gad.353125.125 · Cited by 7
The Role of Hypothalamic Neuropeptides in Regulation of Liver Functions in Health and Disease
Petrescu, A. D., An, S. Y., Venter, J., McMillin, M., & DeMorrow, S. (2023) · Endocrines · doi:10.3390/endocrines4020034 · Cited by 6
RNA-ssisting immunity to heal the heart: a new frontier in therapeutics
Rurik, J. G., Phu, C. L., Mustroph, J., & Buggert, M. (2025) · Cardiology Plus · doi:10.1097/cp9.0000000000000116 · Cited by 6
Albarrati, A., & Gale, N. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47070561 · Cited by 6
Immunotherapies for Aging and Age-Related Diseases: Advances, Pitfalls, and Prospects
Yang, M., Wu, S., Zhang, J., Lu, L., Deng, D., Xia, Q., Lovell, J. F., Shi, X., & Jin, H. (2025) · Research · doi:10.34133/research.0866 · Cited by 7
Alghamdi, E., & Kono, K. (2025) · Cancer Science · doi:10.1111/cas.70223 · Cited by 7
Haines, D. D., Rose, S. A., Cowan, F. M., Mahmoud, F. F., Rizvanov, A. A., & Tósaki, Á. (2025) · Biomolecules · doi:10.3390/biom15111501 · Cited by 7
A senolysis-targeting bioenergetic nanoplatform for diabetic wound healing
Zheng, Z., Wei, X., Jiang, Z., Xie, D., Shi, P., Ma, J., Yu, Q., He, Y., Pang, A., Zeng, J., et al. (2025) · Advanced Composites and Hybrid Materials · doi:10.1007/s42114-025-01509-5 · Cited by 6
Ge, M., Sun, S., Chen, W. L., Xu, Z., Kang, D., Wang, Z., & Guo, Y. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-025-07636-3 · Cited by 6
Fueling the fire: metabolic dysfunction and senescence as drivers of lung aging and disease
Kliment, C. R., Gurkar, A. U., Cárdenes, N., Ramonell, R. P., Finkel, T., & Königshoff, M. (2026) · Physiological Reviews · doi:10.1152/physrev.00024.2025 · Cited by 6
Emerging strategies in senotherapeutics: from broad-spectrum senolysis to precision reprogramming
Zhang, W., Song, S., Zhang, Y., Pan, Y., Hu, D., & Wang, Y. (2026) · npj Aging · doi:10.1038/s41514-026-00355-z · Cited by 6
Wang, R., Chan, S. Y., & Finkel, T. (2026) · Circulation · doi:10.1161/circulationaha.125.075567 · Cited by 6
Navarre, S., Ishibashi, M., Nair, A., Reyes-Torres, I., Belabed, M., Halász, L., Park, M. D., Mattiuz, R., Ounadjela, M., Gunset, G., et al. (2026) · Nature Cancer · doi:10.1038/s43018-026-01167-6 · Cited by 6
Self-citationImmunological consequences of senescence in physiology and pathology
Zubova, A., Pietrocola, F., & Morsli, S. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08335-3 · Cited by 6
Use of CAR T cells as senolytic agents
Carney, E. F. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0324-3 · Cited by 6
Zarroug, S. H. O. (2024) · Journal of Asian Natural Products Research · doi:10.1080/10286020.2024.2414189 · Cited by 7
Escriche‐Navarro, B., Garrido, E., Trujillo, S. C., Labernadie, A., Sancenón, F., García‐Fernández, A., & Martínez‐Máñez, R. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c17748 · Cited by 6
Kv11.1-dependent senescence activates a lethal immune response via tumor necrosis factor alpha
Saatloo, M. V., Delisi, D., Eskandari, N., Krieg, C., & Gentile, S. (2025) · Neoplasia · doi:10.1016/j.neo.2025.101148 · Cited by 6
Słaby, J., Wnuk, M., Błoniarz, D., Stec, P., Szmatoła, T., Kaznowska, E. B., Reich, A., Moros, M., & Lewińska, A. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04028-w · Cited by 6
Huang, L. J., Song, L., Hao, C., Xu, C., Kuang, H., & Qu, A. (2024) · Nano Research · doi:10.26599/nr.2025.94907467 · Cited by 6
Interfacial T cell engineering
Alapan, Y., & Thomas, S. N. (2025) · Nature Reviews Bioengineering · doi:10.1038/s44222-025-00316-3 · Cited by 6
In vitro senescence and senolytic functional assays
Ryan, P., & Lee, J. (2025) · Biomaterials Science · doi:10.1039/d4bm01684j · Cited by 7
mRNA lipid nanoparticles in CAR-T therapy: a novel strategy to improve efficacy
Zhao, Z., Li, M., Zheng, X., Gao, P., Huang, C., Yu, Q., Jin, L., Zhang, L., Zhu, D., & Li, F. (2025) · Nanotechnology · doi:10.1088/1361-6528/add482 · Cited by 6
Targeting senescent cell clearance: An approach to delay aging and age-associated disorders
Qiu, Z., Jia, J., Zou, H., Ao, Y., Liu, B., & Wang, Z. (2021) · Translational Medicine of Aging · doi:10.1016/j.tma.2020.12.001 · Cited by 6
Aghamiri, S. S., & Amin, R. (2024) · Kinases and Phosphatases · doi:10.3390/kinasesphosphatases2020009 · Cited by 6
Alpízar‐Alpízar, W., Skindersoe, M. E., Rasmussen, L., Kriegbaum, M. C., Christensen, I. J., Lund, I. K., Illemann, M., Lærum, O. D., Krogfelt, K. A., Andersen, L. P., et al. (2020) · Microorganisms · doi:10.3390/microorganisms8071019 · Cited by 6
Oral Senescence: From Molecular Biology to Clinical Research
Parkinson, E. K., & Prime, S. S. (2022) · Frontiers in Dental Medicine · doi:10.3389/fdmed.2022.822397 · Cited by 7
Cancer immunotherapy with CAR T cells: well-trodden paths and journey along lesser-known routes
Smole, A. (2022) · Radiology and Oncology · doi:10.2478/raon-2022-0049 · Cited by 8
The drug discovery and therapeutic nano-strategies targeting cellular senescence
Wang, Y., Liu, M., Chen, X., Wang, S., Li, J., Sun, Y., Zheng, X., Zhang, J.-X., & Li, H. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102480 · Cited by 6
Menéndez, J. A., Lupu, R., Martín-Castillo, B., Josep Sardanyés, A., Alarcón, T., Verdura, S., & Cuyàs, E. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1695244 · Cited by 6
Antonangeli, F., Arcuri, E., & Santoni, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1694567 · Cited by 5
Advances in immune cell-based therapeutic agents for the treatment of inflammation-related diseases
Yang, Y., Liu, J., Liu, J., Wei, S., Kong, X., Mu, W., Liu, Y., & Zhang, N. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.01.013 · Cited by 6
Feng, Y. R., Zhi, X., Xiao, T., & Feng, L. (2026) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2026.112158 · Cited by 5
Patusco, R., Gyasi, K., & Kaufmann, A. (2026) · Aging Clinical and Experimental Research · doi:10.1007/s40520-025-03278-z · Cited by 5
Natural killer cells: gatekeepers of healthy aging in longevity medicine
Yang, J. Y., Tu, D. T., Liao, J.-C., & Lee, O. K. (2026) · Inflammation and Regeneration · doi:10.1186/s41232-026-00414-8 · Cited by 5
Senescent Schwann cells as therapeutic targets in nerve regeneration and peripheral neuropathies
Rebolledo, D. L., Khan, M., Melov, S., Höke, A., & Court, F. A. (2026) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2026.01.003 · Cited by 5
Senescent cell heterogeneity: origins, detection, and therapeutic implications
Wu, R., Zhu, J., Kim, H., & Xu, M. (2026) · Trends in Cell Biology · doi:10.1016/j.tcb.2026.03.015 · Cited by 5
Mathew, A. A., Rithvik, A., & Rasool, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1890594 · Cited by 5
CAR T cell therapy beyond cancer: current status, challenges and future prospects
Upadhyay, S., Cho, S., Upmanyu, K., & Gabr, M. T. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02873-4 · Cited by 5
Senescence as a therapeutic target
Meyer, K. R., Lopez-Dominguez, J. A., Maus, M., Kovatcheva, M., & Serrano, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00014-6 · Cited by 5
Høj, K., Baldan, J., Seymour, P. A., Rift, C. V., Hasselby, J. P., Sandelin, A., & Arnes, L. (2024) · Gastro Hep Advances · doi:10.1016/j.gastha.2024.07.002 · Cited by 5
uPAR Immuno-PET in Pancreatic Cancer, Aging, and Chemotherapy-Induced Senescence
Pratt, E. C., Mezzadra, R., Kulick, A. R., Kaminsky, S., Samuels, Z. V., Loor, A., de Stanchina, E., Lowe, S. W., & Lewis, J. S. (2024) · Journal of Nuclear Medicine · doi:10.2967/jnumed.124.268278 · Cited by 5
Self-citationGoodbye, senescent cells: CAR-T cells unleashed to fight ageing
Micco, R. D. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00792-2 · Cited by 5
Senolytic Vaccines from the Central and Peripheral Tolerance Perspective
Vasilieva, M., Shatalova, R. O., Matveeva, K. S., Shindyapin, V. V., Minskaia, E., Ivanov, R. A., & Shevyrev, D. (2024) · Vaccines · doi:10.3390/vaccines12121389 · Cited by 5
Exosomal dynamics: Bridging the gap between cellular senescence and cancer therapy
Aswani, B. S., Sajeev, A., Hegde, M., Mishra, A., Abbas, M., Vayalpurayil, T., Sethi, G., & Kunnumakkara, A. B. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112045 · Cited by 6
Da, J., Hu, H., Wang, L., Wang, Z., Chen, H., Xie, Y., Li, T., Wang, J., Zhong, M., Dang, W., et al. (2025) · Nano Letters · doi:10.1021/acs.nanolett.5c01741 · Cited by 5
Mini review: Gene therapy targets for aging-associated diseases
Shchukina, E., Eremin, I. I., Mazunin, I., & Alexey, M. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152708 · Cited by 5
Broadway, R., Patel, N. M., Hillier, L. E., El-briri, A., Korneva, Y. S., Zinovkin, D. A., & Pranjol, M. Z. I. (2021) · Life · doi:10.3390/life11080788 · Cited by 5
Simulation of delaminations in composite laminates
Gudimetla, P., Kharidi, A., & Yarlagadda, P. K. D. V. (2009) · QUT ePrints (Queensland University of Technology) · Cited by 5
The potential for senotherapy as a novel approach to extend life quality in veterinary medicine
Williams, Z. J., Chow, L., Dow, S., & Pezzanite, L. M. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1369153 · Cited by 5
SATB1, senescence and senescence‐related diseases
Qi, W., Bai, J., Wang, R., Zeng, X., & Zhang, L. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31327 · Cited by 6
Cellular Senescence in Diffuse Gliomas: From Physiopathology to Possible Treatments
Ordóñez-Rubiano, E. G., Cómbita, A. L., Baldoncini, M., Payán‐Gómez, C., Gómez-Amarillo, D. F., Hakim, F., Camargo, J., Zorro-Sepúlveda, V., Luzzi, S., Zorro, Ó., et al. (2024) · World Neurosurgery · doi:10.1016/j.wneu.2024.08.060 · Cited by 6
Zhang, K., Yin, Q., Ma, Y. F., Cao, M., Li, L., Jin, X. M., & Leng, J. (2025) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2025.2479229 · Cited by 5
Thermogenic T cells: a cell therapy for obesity?
Beier, U. H., Baker, D. J., & Baur, J. A. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00034.2022 · Cited by 5
Lessons from Sicilian centenarians for anti-ageing medicine. The Oxi-inflammatory status
Caruso, C., Accardi, G., Aiello, A., Calabrò, A., Ligotti, M. E., & Candore, G. (2022) · Translational Medicine UniSa · doi:10.37825/2239-9747.1036 · Cited by 5
Multiple characteristic alterations and available therapeutic strategies of cellular senescence
Zhao, Y., Li, H., Guo, Q., & Hui, H. (2023) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2200178 · Cited by 5
Hautalterung – zelluläre Seneszenz
Scharffetter‐Kochanek, K., Wang, Y., Makrantonaki, E., Crișan, D., Wlaschek, M., Geiger, H., & Maity, P. (2023) · Die Dermatologie · doi:10.1007/s00105-023-05201-x · Cited by 5
Single‐cell analysis of human dermal fibroblasts isolated from a single male donor over 35 years
Itai, E., Atsugi, T., Inomata, K., Yamashita, M., Kaji, K., Nanba, D., & Naru, E. (2023) · Experimental Dermatology · doi:10.1111/exd.14929 · Cited by 5
Véret, D., & Brondello, J. (2020) · médecine/sciences · doi:10.1051/medsci/2020220 · Cited by 5
Immuno(T)herapy for age‐related diseases
Gabandé‐Rodríguez, E., Pfeiffer, M., & Mittelbrunn, M. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202216301 · Cited by 5
Procyanidin C1 is a natural agent with senolytic activity against aging and age-related diseasesPreprint
Xu, Q., Fu, Q., Li, Z., Liu, H., Wang, Y., Lin, X., He, R., Zhang, X., Campisi, J., Kirkland, J. L., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.14.439765 · Cited by 5
Unleashing CAR T cells to delay metabolic aging
Bartley, J. M., & Xu, M. (2024) · Nature Aging · doi:10.1038/s43587-024-00576-5 · Cited by 5
A Conversation with ChatGPT on Contentious Issues in Senescence and Cancer Research
Elshazly, A. M., Shahin, U., Shboul, S. A., Gewirtz, D. A., & Saleh, T. (2024) · Molecular Pharmacology · doi:10.1124/molpharm.124.000871 · Cited by 4
Drug Delivery Strategies for Age-Related Diseases
Yoshihara, K., & Horiguchi, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168693 · Cited by 4
Senescent cells: a therapeutic target in correction of aging
Kirichenko, T. V., Markina, Y. V., Markin, A. M., Eremin, I. I., & Deev, R. V. (2024) · Восстановительные биотехнологии, профилактическая, цифровая и предиктивная медицина. · doi:10.17116/rbpdpm2024103153 · Cited by 4
Zhu, C., Wang, F., Cheng, Z., Zhang, L. L., & Li, H. (2025) · Precision medicine and engineering. · doi:10.1016/j.preme.2025.100024 · Cited by 5
Self-citationTak, K. Y., Kim, J., Park, M., Kim, W., Lee, S., Park, N., Kim, M. J., Kang, J.-B., Koh, Y., Yang, H. Y., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00857-7 · Cited by 4
Gao, Y., Zhou, Y., He, X., Lin, H., Fang, K., Hou, Q., Wang, H., Zhang, H., Zhang, Y., & Li, Y. (2025) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2025.2518634 · Cited by 4
Mechanisms of natural killer cell-mediated clearance of senescent renal tubular epithelial cells
Funk, N. D., Sinning, J., Schaser, P., Sörensen-Zender, I., Wulfmeyer, V. C., Schmidt-Ott, K. M., Brand, K., Halle, S., & Schmitt, R. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1597230 · Cited by 4
Yu, A., Ma, C., & Hu, M. (2025) · Cells · doi:10.3390/cells14151153 · Cited by 4
Guan, Y., Bai, X., Li, C., Zhang, Z., He, Q., Chen, L., Xie, Y., & Wang, Z. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101871 · Cited by 4
Reversing coma by senolytics and stem cells: the future is now
Ichim, T. E., Ramos, R. A., Rath, A. V., Castellano, J., Azimi, N. A., Veltmeyer, J. D., Koumjian, M. P., Nicole, E. U., Bajnath, A., Lin, E. S., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07099-6 · Cited by 4
The pathophysiological mechanisms of immunosenescence in coronary artery disease
Bie, H., & Tao, Z. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1686947 · Cited by 4
Wirestam, L., Karlsson, J., Welin, A., Alvarez‐Gómez, J. A., Wetterö, J., Sjöwall, C., & Enocsson, H. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01897-4 · Cited by 4
Mechanisms of aging in the cardiovascular system: challenges and opportunities
Zhao, X., Yang, X., Lin, Y., Lei, R., Ding, W., He, X.-Y., Cao, Y. J., Zhang, D., Liu, P., Liang, M., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1635736 · Cited by 4
CAR-T cell therapy: A therapeutic strategy for cancer treatment
Sharif, S., Sharma, U., & Yadav, A. K. (2025) · Seminars in Oncology · doi:10.1016/j.seminoncol.2025.152430 · Cited by 4
Natural killer cell immunotherapies beyond cancer
Guo, X., Chen, S., Wang, R., Ma, S., & Li, N. (2025) · Cell investigation. · doi:10.1016/j.clnves.2025.100048 · Cited by 4
Decoding senescent drivers in Alzheimer's disease: From bench to bedside
Zhou, R., Lin, X., Liao, Z., Lin, J., Zheng, R., Ni, H., Liu, W., Feng, Z., He, Q., Lin, X., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102978 · Cited by 4
Immunosuppressive macrophages determine the effect of cellular senescence on tumor progression
Lalinde-Gutiérrez, M., Pérez‐Ramos, S., Rodilla, V., Garcia-Baucells, P., Julia, P.-B., Berenguer‐Molins, P., Nonell, L., Agustí-Barea, I., Mueller, C. G., & Arribas, J. (2026) · Science Advances · doi:10.1126/sciadv.adx2988 · Cited by 4
Fibroblast circSamd4 promotes cardiac fibrosis via activating plasminogen activator inhibitor-1
Chen, Y., Zhang, Z., Cheng, Y., Chen, X., Zhou, J., Wei, Z., Yao, H., Zhang, S., Kong, Q., Tang, H., et al. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104018 · Cited by 4
Steegen, L., & Grootaert, M. O. J. (2026) · Cells · doi:10.3390/cells15020114 · Cited by 4
Meng, B., Qu, Y., Yang, B., Fu, C., He, Y., Li, J., Wan, R., Li, X., Xue, Z., Cao, Z., et al. (2026) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01584-5 · Cited by 4
Self-citationCAR-T cells targeting activated hepatic stellate cells ameliorate liver fibrosis in mouse models
Zhang, Y.-W.-Q., Ren, H., Zhang, M., Pan, X., Li, X., Zhang, J., Xia, P., Ma, W., Wu, T., Chen, X., et al. (2026) · JHEP Reports · doi:10.1016/j.jhepr.2026.101747 · Cited by 4
Self-citationZhou, Z., Li, X., Wang, Y., Liang, L., Wang, C., Sun, Y., Wu, D., & Qiu, Y. (2026) · Nature Communications · doi:10.1038/s41467-026-69996-8 · Cited by 4
Self-citationChronic Kidney Disease and Cellular Senescence
Morevati, M., Tavenier, J., Scheibye‐Knudsen, M., Houlind, M. B., Hedayati, A., & Hornum, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27073205 · Cited by 4
uPAR is highly expressed in recurrent glioblastoma and represents a candidate CAR T cell target
Maich, W. T., Shaikh, M. V., Puri, A., Rossotti, M. A., Grewal, S., Khanna, A., Anand, A., Mikolajewicz, N., Seyfrid, M., McKenna, D., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.aea8381 · Cited by 4
Godlewski, A., & Dziaman, T. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1872180 · Cited by 4
Precise Nutrition and Functional Foods
Ivanović, N., Hippe, B., Lilja, S., & Haslberger, A. G. (2022) · Springer eBooks · doi:10.1007/978-3-031-10153-3_10 · Cited by 4
Pharmacology of Aging: Drosophila as a Tool to Validate Drug Targets for Healthy Lifespan
Cochemé, H. M., & dos Santos, E. (2024) · doi:10.59368/agingbio.20240034 · Cited by 4
Santos‐Sousa, D., da Rosa, S., & Filippi‐Chiela, E. C. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112052 · Cited by 5
The road ahead for chimeric antigen receptor T cells
Stewart, C. M., Siegler, E. L., & Kenderian, S. S. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf047 · Cited by 4
Metadata
- Authors
- Amor, C., Feucht, J., Leibold, J., Ho, Y.-J., Zhu, C., Alonso-Curbelo, D., Mansilla-Soto, J., Boyer, J. A., Li, X., Giavridis, T., Kulick, A., Houlihan, S., Peerschke, E., Friedman, S. L., Ponomarev, V., Piersigilli, A., Sadelain, M., & Lowe, S. W.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Sadelain, Michel
- Lowe, Scott W.
- ORCID
- Venue
- Nature
- Published
- 2020-06-17
- Volume
- 583
- Issue
- 7814
- Pages
- 127-132
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC7583560
- OpenAlex
- W3036603151
- Semantic Scholar
- 04e18a651e78de49d44a74b1db3d968208b4c3a1
- Cited by
- 1,098
- References
- 60
- Citations by year
- 2026: 194 · 2025: 236 · 2024: 208 · 2023: 147 · 2022: 135 · 2021: 131 · 2020: 45
- FWCI
- 68.89
- Type
- journal article
- Language
- en
- Update notices
- correction (2024-02-21)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health (U54OD020355)
- National Institute on Aging (AG065396, R56AG016379, R01AG016379, R01AG065396)
- National Cancer Institute (P01CA129243, P30CA008748)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK056621)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- cellular senescence, chimeric antigen receptor T cells, urokinase-type plasminogen activator receptor, liver fibrosis, lung adenocarcinoma, senescence-associated secretory phenotype, tissue homeostasis
- MeSH terms
- Receptors, Chimeric Antigen, Adenocarcinoma, Aging, Animals, Carbon Tetrachloride, Female, Humans, Liver Cirrhosis, Longevity, Lung Neoplasms, Male, Receptors, Cell Surface, Rejuvenation, T-Lymphocytes, T-Lymphocytes, Cytotoxic, Cellular Senescence, Mice, Receptors, Urokinase Plasminogen Activator, Heterografts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
